Key result
Long-term therapeutic dicoumarol therapy after myocardial infarction failed to prevent recurrent infarctions and resulted in 8 deaths compared to 0 deaths in the low-dose control group.
RCT (n=50)
Blinded (tablets identical in appearance)
Random selection
No
Answers are grounded in this paper and cite their sources.
May warrant avoiding long-term dicoumarol post-MI; challenges early positive reports and supports reassessment of anticoagulation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
MacMillan et al. (1965) conducted an RCT in Myocardial infarction (n=50). Dicoumarol vs. Low-dose dicoumarol (1 mg tablets, maximum 1.5 mg/day) was evaluated on Mortality. Long-term therapeutic dicoumarol therapy after myocardial infarction failed to prevent recurrent infarctions and resulted in 8 deaths compared to 0 deaths in the low-dose control group.
Synapse has enriched 10 related papers. Consider them for comparative context: